Epidemiology, health policy and public health implications of visual impairment and age-related eye diseases in mainland China

• Published in: Frontiers in public health Vol. 10; p. 966006
• Main Authors: Li, Cong, Zhu, Bo, Zhang, Jie, Guan, Peng, Zhang, Guisen, Yu, Honghua, Yang, Xiaohong, Liu, Lei
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 09.11.2022
• Subjects: age-related eye diseases; Aged; China - epidemiology; epidemiology; Health Policy; Humans; incidence; prevalence; Public Health; Public Policy; risk factors; Vision Disorders - epidemiology; China; epidemiology; prevalence; risk factors; age-related eye diseases; incidence
• ISSN: 2296-2565; 2296-2565
• DOI: 10.3389/fpubh.2022.966006

The prevalence of visual impairment (VI) and age-related eye diseases has increased dramatically with the growing aging population in mainland China. However, there is limited comprehensive evidence on the progress of ophthalmic epidemiological research in mainland China to enhance our awareness of the prevention of eye diseases to inform public health policy. Here, we conducted a literature review of the population-based epidemiology of VI and age-related eye diseases in mainland China from the 1st of January 1946 to the 20th of October 2021. No language restrictions were applied. There was significant demographic and geographic variation in the epidemic of VI and age-related eye diseases. There are several factors known to be correlated to VI and age-related eye diseases, including age, gender, family history, lifestyle, biological factors, and environmental exposures; however, evidence relating to genetic predisposition remains unclear. In addition, posterior segment eye diseases, including age-related macular degeneration and diabetic retinopathy, are amongst the major causes of irreversible visual impairments in the senile Chinese population. There remains a significant prevention gap, with only a few individuals showing awareness and achieving optimal medical care with regards to age-related eye diseases. Multiple challenges and obstacles need to be overcome, including the accelerated aging of the Chinese population, the lack of structured care delivery in many underdeveloped regions, and unequal access to care. Despite the progress to date, there are few well-conducted multi-center population-based studies following a single protocol in mainland China, which findings can hopefully provide valuable cues for governmental decision-making and assist in addressing and halting the incidence of VI and age-related eye diseases in China.